<DOC>
	<DOCNO>NCT00362999</DOCNO>
	<brief_summary>The hypothesis proven histamine iontophoresis measurement microvascular blood flow laser Doppler flowmetry use reliable marker characterize normal microvascular cutaneous response histamine .</brief_summary>
	<brief_title>Validation Laser Doppler Flowmetry Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations Histamine Metabolism</brief_title>
	<detailed_description>The specific aim study validate iontophoresis ( measurement microvascular blood flow laser Doppler flowmetry ) pediatric cohort surrogate marker capable reliably characterize normal physiologic response cutaneous microvasculature histamine . In future study laser Doppler flowmetry ultimately use ass whether microvascular blood flow determine previously validate laser Doppler technique use reliable surrogate endpoint capable functionally discriminate effect polymorphisms gene quantitatively important histamine metabolism . The hypothesis proven histamine iontophoresis measurement microvascular blood flow laser Doppler flowmetry use reliable marker characterize normal microvascular cutaneous response histamine .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<criteria>diagnose allergic rhinitis attend Pediatrician Allergist ( diagnosis make clinical ground positive skin test RAST environmental allergen , tree , grass , weed , mold , animal dander , cockroach , dust mite ) history evidence McCune Albright syndrome , immunodeficiency , mastocytosis , receipt allergy shot , chronic skin disease , liver kidney disease , cancer , neurological movement disorder , uncontrolled ADHD , evidence eczema currently past 2 year , history anaphylaxis anaphylactic like episode , evidence pregnancy ( urinary hCG ) lactation , use antihistamine 10 day prior skin testing , use systemic corticosteroid tricyclic antidepressant 30 day prior skin testing , presence condition would cause difficulty adherence study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Allergic</keyword>
	<keyword>Rhinitis</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Histamine</keyword>
</DOC>